Company profile for TesoRx Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

TesoRx is a clinical-stage pharmaceutical company pioneering an advanced oral drug-delivery platform targeting androgen deficiency and oncology. Founded in 2010 and led by CEO Ramachandran ?TR? Thirucote, it develops first-in-class oral testosterone therapy TSX?002 (Phase II underway, Phase III anticipated in early 2026) and pipeline candidates like THG?1001 and bladder-cancer agent TBC?1002

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
325 Sharon Park Drive, Suite 739, Menlo Park, CA 94025
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Cosmoprof

Cosmoprof

Not Confirmed

envelop Contact Supplier

Cosmoprof

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty